Will Ceftazidime-Avibactam Replace Polymyxins in Asia?

Sock Hoon Tan^{1

2}, Narendran Koomanan¹, Shimin Jasmine Chung³, Andrea Lay-Hoon Kwa^{1

4

5}

Affiliations

¹ Department of Pharmacy, Singapore General Hospital, Singapore.
² Department of Pharmacy, Tan Tock Seng Hospital, Singapore.
³ Department of Infectious Diseases, Singapore General Hospital, Singapore.
⁴ Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
⁵ Singhealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore.

Comment

Sock Hoon Tan et al. Clin Infect Dis. 2021.

. 2021 Nov 2;73(9):1743-1744.

doi: 10.1093/cid/ciab390.

Sock Hoon Tan^{1

2}, Narendran Koomanan¹, Shimin Jasmine Chung³, Andrea Lay-Hoon Kwa^{1

4

5}

¹ Department of Pharmacy, Singapore General Hospital, Singapore.
² Department of Pharmacy, Tan Tock Seng Hospital, Singapore.
³ Department of Infectious Diseases, Singapore General Hospital, Singapore.
⁴ Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
⁵ Singhealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore.

No abstract available

Comment on

Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
Strich JR, Ricotta E, Warner S, Lai YL, Demirkale CY, Hohmann SF, Rhee C, Klompas M, Palmore T, Powers JH, Dekker JP, Adjemian J, Matsouaka R, Woods CW, Danner RL, Kadri SS. Strich JR, et al. Clin Infect Dis. 2021 Feb 16;72(4):611-621. doi: 10.1093/cid/ciaa061. Clin Infect Dis. 2021. PMID: 32107536 Free PMC article.